Riverview Trust Company’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-31
Closed -$18K 700
2022
Q3
$18K Hold
31
0.02% 382
2022
Q2
$17K Buy
+31
New +$15.7K 0.01% 432

Other funds holding AGL

Riverview Trust Company's AGL Position: Q4 2022 in Review

Riverview Trust Company sold out of Agilon Health (AGL) in Q4 2022, closing a stake of 31 shares — an estimated $18K sold.

Riverview Trust Company first reported a position in AGL in Q2 2022 and held it in 2 quarters. The position peaked at $18K in Q3 2022. 166 funds tracked by Wall St. Rank hold AGL as of Q4 2022.

  • Riverview Trust Company reported no remaining Agilon Health position as of Q4 2022 after selling out during the quarter.
  • Riverview Trust Company sold 31 Agilon Health shares in Q4 2022, an estimated $18K.
  • Riverview Trust Company first reported a position in Agilon Health in Q2 2022 and held it in 2 quarters.
  • Riverview Trust Company's Agilon Health position peaked at $18K in Q3 2022.
  • 166 funds tracked by Wall St. Rank held Agilon Health as of Q4 2022.

Based on Riverview Trust Company's 13F filing for Q4 2022, filed 26 Jan 2023.